198 related articles for article (PubMed ID: 2866274)
1. Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist.
Laubie M; Poignant JC; Scuvée-Moreau J; Dabire H; Dresse A; Schmitt H
J Pharmacol; 1985; 16(3):259-78. PubMed ID: 2866274
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.
van Zwieten PA; Thoolen MJ; Jonkman FA; Wilffert B; de Jonge A; Timmermans PB
Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):130-49. PubMed ID: 2870686
[TBL] [Abstract][Full Text] [Related]
3. Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine.
Dabiré H; Mouillé P; Andréjak M; Fournier B; Schmitt H
Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):252-70. PubMed ID: 6121540
[TBL] [Abstract][Full Text] [Related]
4. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
5. Contribution of alpha 2-adrenoceptors to the central cardiovascular effects of clonidine and S 8350 in anaesthetized rats.
Deckert V; Lachaud V; Parini A; Elghozi JL
Clin Exp Pharmacol Physiol; 1991 Oct; 18(10):401-8. PubMed ID: 1684919
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
Szabo B; Bock C; Nordheim U; Niederhoffer N
Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of alpha-1 adrenoceptor stimulation on cardiac sympathetic neurotransmission in pithed normotensive rats.
de Jonge A; van den Berg G; Qian JQ; Wilffert B; Thoolen MJ; Timmermans PB; van Zwieten PA
J Pharmacol Exp Ther; 1986 Feb; 236(2):500-4. PubMed ID: 2868121
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.
Hamilton TC; Longman SD
Br J Pharmacol; 1982 Jan; 75(1):13-21. PubMed ID: 6122478
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its stereoisomers on some central and peripheral actions of alpha 2-agonists.
Joly G; Mouillé P; Schmitt H
Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):180-91. PubMed ID: 2865936
[TBL] [Abstract][Full Text] [Related]
12. Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits.
Szabo B; Hedler L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):648-57. PubMed ID: 2615856
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
Van Zwieten PA
Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular actions of medetomidine and their reversal by atipamezole.
Savola JM
Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
[TBL] [Abstract][Full Text] [Related]
15. Sympathoinhibition by rilmenidine in conscious rabbits: involvement of alpha 2-adrenoceptors.
Szabo B; Urban R; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):593-600. PubMed ID: 7907776
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of B-HT 958, an alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.
Kobinger W; Pichler L
Eur J Pharmacol; 1984 Jan; 97(1-2):67-73. PubMed ID: 6141948
[TBL] [Abstract][Full Text] [Related]
17. Pressor effects of the alpha 2-adrenoceptor agonist B-HT 933 in anaesthetized and haemorrhagic rats: comparison with the haemodynamic effects of amidephrine.
MacLean MR; Thomson M; Hiley CR
Br J Pharmacol; 1989 Jun; 97(2):419-32. PubMed ID: 2569342
[TBL] [Abstract][Full Text] [Related]
18. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
[TBL] [Abstract][Full Text] [Related]
19. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
Sanders KH; Jurna I
Eur J Pharmacol; 1985 Apr; 110(2):181-90. PubMed ID: 3987812
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]